KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Income from Continuing Operations (2016 - 2026)

Bio-Rad Laboratories has reported Income from Continuing Operations over the past 18 years, most recently at 527100000.0 for Q1 2026.

  • Quarterly Income from Continuing Operations fell 923.59% to 527100000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 168800000.0 through Mar 2026, up 107.8% year-over-year, with the annual reading at 759900000.0 for FY2025, 141.2% up from the prior year.
  • Income from Continuing Operations was 527100000.0 for Q1 2026 at Bio-Rad Laboratories, down from 720000000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 827814000.0 in Q4 2022 and troughed at 3367315000.0 in Q1 2022.
  • The 5-year median for Income from Continuing Operations is 64000000.0 (2025), against an average of 345653882.35.
  • Year-over-year, Income from Continuing Operations surged 514.75% in 2024 and then crashed 923.59% in 2026.
  • A 5-year view of Income from Continuing Operations shows it stood at 827814000.0 in 2022, then plummeted by 57.75% to 349736000.0 in 2023, then plummeted by 304.67% to 715800000.0 in 2024, then skyrocketed by 200.59% to 720000000.0 in 2025, then tumbled by 173.21% to 527100000.0 in 2026.
  • Per Business Quant, the three most recent readings for BIO's Income from Continuing Operations are 527100000.0 (Q1 2026), 720000000.0 (Q4 2025), and 341900000.0 (Q3 2025).